EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study

Stephan von Haehling, Matthias Müller-Hennessen, Tania Garfias-Veitl, Alina Goßling iD, Johannes T Neumann iD, Nils A Sörensen iD, Paul M Haller, Tau Hartikainen, Jörn Ole Vollert, Martin Möckel, Stefan Blankenberg, Dirk Westermann und 1 weitere

Cells · 2023

DOI: 10.3390/cells12071062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Stephan von Haehling und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Pneumology, University of Göttingen Medical Center, 37075 Göttingen, Germany. Hauptthemen laut MEDLINE: Acute Coronary Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In light of overlapping symptoms, discrimination between non-ST-elevation (NSTE) acute coronary syndrome (ACS) and acute heart failure (HF) is challenging, particularly in patients with equivocal clinical presentation for suspected ACS. We sought to evaluate the diagnostic and prognostic properties of copeptin in this scenario.

Methods

Data from 1088 patients from a single-center observational registry were used to test the ability of serial high sensitivity cardiac troponin T (hs-cTnT)—compared to copeptin, or a combination of copeptin with hs-cTnT—to discriminate acute HF from uncomplicated non-ST-elevation myocardial infarction (NSTEMI) and to evaluate all-cause mortality after 365 days. Patients with STEMI, those with unstable angina and either normal or undetectable hs-cTnT concentrations were excluded. The findings were validated in an independent external NSTE-ACS cohort.

Results

A total of 219 patients were included in the analysis. The final diagnosis was acute HF in 56 and NSTE-ACS in 163, with NSTEMI in 78 and unstable angina having stable elevation of hs-cTnT >ULN in 85. The rate of all-cause death at 1 year was 9.6% and occurred significantly more often in acute HF than in NSTE-ACS (15 vs. 6%, p < 0.001). In the test cohort, the area under the receiver operator curve (AUC) for the discrimination of acute HF vs. NSTE-ACS without HF was 0.725 (95% confidence interval [CI] 0.625–0.798) for copeptin and significantly higher than for hs-cTnT at 0 h (AUC = 0.460, 0.370–0.550) or at 3 h (AUC = 0.441, 0.343–0.538). Copeptin and hs-cTnT used either as continuous values or at cutoffs optimized to yield 90% specificity for acute HF were associated with significantly higher age- and sex-adjusted risk for all-cause mortality at 365 days. The findings from the test cohort were consistently replicated in the independent external NSTE-ACS validation cohort.

Conclusions

High concentrations of copeptin in patients with suspected NSTE-ACS and equivocal clinical presentation suggest the presence of acute HF compared to uncomplicated NSTE-ACS and are associated with higher rates of all-cause death at 365 days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeHumansMaleFemaleMiddle AgedAgedAged, 80 and overAngina, UnstableBiomarkersTroponin TGlycopeptidesAntigensIntermediate Filament Proteins

Stichwörter der Autor:innen

acute coronary syndromeacute heart failurecopeptinhigh-sensitivity cardiac troponinoutcomes

Substanzen

BiomarkersTNNT2 protein, humanTroponin TcopeptinsGlycopeptidesTCHH protein, humanAntigensIntermediate Filament Proteins

Autor:innen und Institutionen

  • Department of Cardiology and Pneumology, University of Göttingen Medical Center, 37075 Göttingen, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, 37075 Göttingen, Germany.
  • Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Department of Cardiology, University Heart & Vascular Center Hamburg, Martinistrasse 52, 20246 Hamburg, Germany.
  • German Center of Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, 10115 Hamburg, Germany.
  • University Heart Center Freiburg Bad Krozingen, Department of Cardiology and Angiology, University Freiburg, 79110 Freiburg, Germany.

ORCID-Profile: Alina Goßling, Johannes T Neumann, Nils A Sörensen, Evangelos Giannitsis

Zitieren

APA

von Haehling, S., Müller-Hennessen, M., Garfias-Veitl, T., Goßling, A., Neumann, J. T., Sörensen, N. A., Haller, P. M., Hartikainen, T., Vollert, J. O., Möckel, M., Blankenberg, S., Westermann, D., & Giannitsis, E. (2023). Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study. Cells. https://doi.org/10.3390/cells12071062

Vancouver

von Haehling S, Müller-Hennessen M, Garfias-Veitl T, Goßling A, Neumann JT, Sörensen NA, et al. Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study. Cells. 2023. doi:10.3390/cells12071062

BibTeX
@article{vonHaehling2023,
  author = {von Haehling, Stephan and Müller-Hennessen, Matthias and Garfias-Veitl, Tania and Goßling, Alina and Neumann, Johannes T and Sörensen, Nils A and Haller, Paul M and Hartikainen, Tau and Vollert, Jörn Ole and Möckel, Martin and Blankenberg, Stefan and Westermann, Dirk and Giannitsis, Evangelos},
  title = {Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT—A Derivation and External Validation Study},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12071062}
}
Kostenlos starten →